Company news
TheraCryf PLC news in 2018
TheraCryf PLC's news releases, calls and decks from 2018, newest first.
Interim Results
December 12, 2018
Nominated Adviser Status
December 10, 2018
Poster Presentation of SFX-01 and Trial Update
December 4, 2018
Notification of Half Year Results
December 3, 2018
Investor Presentation in Manchester
November 19, 2018
Placing
October 18, 2018
Investor Symposium
September 18, 2018
Notice of Investor Symposium
September 11, 2018
Final Patient Recruited in STEM Phase IIa Trial
July 25, 2018
Grant of share options, issue of equity and TVR
July 10, 2018
Evgen Pharma (EVG): 2018, a pivotal year
June 29, 2018
Evgen Pharma (EVG): Encouraging interim data fr...
June 13, 2018
Interim Update on STEM Trial
June 11, 2018
Upcoming Investor Presentations
May 14, 2018
Presentation at World Orphan Drug Congress USA
April 24, 2018
Research Collaboration with Imperial College
March 20, 2018
Update on Novel Sulforaphane Analogues
March 5, 2018
Poster Presentation of SFX-01 Mechanistic Data
January 15, 2018
Notification of Major Interest in Shares
January 10, 2018
Total Voting Rights
January 2, 2018
Decks in 2018
- Evgen Pharma — FY2018 Earnings Presentation
Earnings · 41 slides · June 2018
- Evgen Pharma — Investor Presentation (May 2018)
Investor deck · 29 slides · May 2018